JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 1988; 67:611-615
© 1988 International Anesthesia Research Society
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vickery, R. G.
Right arrow Articles by Maze, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vickery, R. G.
Right arrow Articles by Maze, M.

Anesthetic and Hemodynamic Effects of the Stereoisomers of Medetomidine, an {alpha}2-Adrenergic Agonist, in Halothane-Anesthetized Dogs

Ross G. Vickery, BS, Brett C. Sheridan, Ira S. Segal, MD, and Mervyn Maze, MB

Received from the Anesthesiology Service (112A), Veterans Administration Medical Center, Palo Alto, California, and the Department of Anesthesia, Stanford University, Stanford, California.

Abstract

The anesthetic-sparing and hemodynamic effects of the Stereoisomers of the highly selective {alpha}2-adrenergic agonist medetomidine were studied in halothane-anesthetized dogs. Male beagles were anesthetized with halothane in oxygen. After a 2-hour equilibration period, halothane MAC and baseline hemodynamic functions were determined. DL-(n = 7), D-(n = 5), or L-medetomidine (n = 5) at 1, 3, and 10 µg/kg was administered via a right atrial port over 15 minutes while each dog was given halothane at the MAC dose for that animal. Twenty minutes after the end of infusion (when the hemodynamic variables were stable), hemodynamic function was reassessed. Halothane MAC was then redetermined. MAC for halothane significantly decreased after DL-medetomidine administration in a dose-dependent fashion to the extent that at the highest dose (10 µg/kg) the halothane MAC was <0.1%. This effect could be mimicked by the D-isomer, whereas the L-isomer was without effect. Neither isomer changed the mean arterial pressure, whereas only the D-isomer significantly decreased heart rate and cardiac output. Medetomidine, the highly selective {alpha}2-adrenergic agonist, reduces the MAC for volatile anesthesia by a greater degree than with any other physiologic, pharmacologic, or pathologic intervention thus far reported. The fact that this effect is stereospecific suggests a structure activity relation that can be accounted for by a homogeneous receptor population. The role of medetomidine as a supplemental anesthetic agent appears promising and requires further investigation.

Key Words: SYMPATHETIC NERVOUS SYSTEM, PHARMACOLOGY—medetomidine • POTENCY, ANESTHETIC—MAC




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. F. A. Hendrickx, E. I. Eger II, J. M. Sonner, and S. L. Shafer
Is Synergy the Rule? A Review of Anesthetic Interactions Producing Hypnosis and Immobility
Anesth. Analg., August 1, 2008; 107(2): 494 - 506.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
R. E. Hofer, J. Sprung, M. G. Sarr, and D. J. Wedel
Anesthesia for a patient with morbid obesity using dexmedetomidine without narcotics: [L'anesthesie chez un patient obese morbide avec la dexmedetomidine sans narcotiques]
Can J Anesth, February 1, 2005; 52(2): 176 - 180.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Burke and D. J. Henderson
Chirality: a blueprint for the future
Br. J. Anaesth., April 1, 2002; 88(4): 563 - 576.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Horvath, G. Joo, I. Dobos, W. Klimscha, G. Toth, and G. Benedek
The Synergistic Antinociceptive Interactions of Endomorphin-1 with Dexmedetomidine and/or S(+)-Ketamine in Rats
Anesth. Analg., October 1, 2001; 93(4): 1018 - 1024.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
S. Inomata, S. Kihara, Y. Yaguchi, Y. Baba, Y. Kohda, and H. Toyooka
Reduction in standard MAC and MAC for intubation after clonidine premedication in children
Br. J. Anaesth., November 1, 2000; 85(5): 700 - 704.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. E. Hall, T. D. Uhrich, J. A. Barney, S. R. Arain, and T. J. Ebert
Sedative, Amnestic, and Analgesic Properties of Small-Dose Dexmedetomidine Infusions
Anesth. Analg., March 1, 2000; 90(3): 699 - 705.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Inomata, Y. Yaguchi, and H. Toyooka
The Effects of Clonidine Premedication on Sevoflurane Requirements and Anesthetic Induction Time
Anesth. Analg., July 1, 1999; 89(1): 204 - 204.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. P. Lakhlani, L. B. MacMillan, T. Z. Guo, B. A. McCool, D. M. Lovinger, M. Maze, and L. E. Limbird
Substitution of a mutant alpha 2a-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo
PNAS, September 2, 1997; 94(18): 9950 - 9955.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1988 by the International Anesthesia Research Society.